Simon Basseyn, M.D., has joined TCG Crossover as part of the $824 million firm’s investment team, which specializes in the life sciences.
Previously, Basseyn was a senior analyst at a life-sciences focused hedge fund based in New York called Ghost Tree Capital.
“I am thrilled to join the talented founding investment team at TCG X and eager to begin investing in companies developing innovative science across the crossover and public stages,” said Basseyn.
Chen Yu, founding managing partner at TCG X said that Basseyn’s strong technical background and diverse . . .
Unlock this article instantly, along with the rest of our premium content and daily, weekly and monthly newsletters. We offer pay-as-you-go monthly subscriptions and discounted annual subscriptions with additional benefits: access to Alternatives Watch Research articles and our Annual Investor Compendium.